Description:

AMC-061 Protocol Deviation Form (DEV) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

Link:

https://clinicaltrials.gov/ct2/show/NCT00890747

Keywords:

Brain Neoplasms

Clinical Trial

Central Nervous System Neoplasms

On-Study Form

Versions (2) ▾

8/26/12
6/12/17

Uploaded on:

June 12, 2017

DOI:

No DOI assigned. To request one pleaselog in.

License:

Creative Commons BY-NC 3.0

Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

HIV Cancer Sunitinib NCT00890747 AMC-061

Details

No Instruction available.

StudyEvent: AMC-061 Protocol Deviation Form (DEV)
1. No Instruction available.

Header Module

AMC Protocol Number

Date Protocol Deviation Occurred

mm/dd/yyyy

Specify deviation

Protocol Deviation Information

Protocol Deviation Description (Reason for deviation from the protocol)

Action Taken (What steps were taken to resolve this deviation)

Is the protocol deviation associated with a particular participant

Yes

Participant ID

Did the protocol deviation result in an adverse event

Yes

Is the participant still being followed (will the participant continue in the study)

Yes

Participating Investigator or Physician Name

Back to the top of the page

Contact

Please use this form for feedback, questions and suggestions for improvements.